Grant: Discovery Grants Program - Individual
Brock University
$21,987.00
Food bioactives and bone metabolism
FY 2010-11
Summary
Bone tissue begins to deteriorate as the body's ability to produce estrogen and testosterone is compromised with aging. Food bioactives, naturally present in foods such as flaxseed and fish oil, may help preserve normal bone cell function during aging. Food bioactives of particular interest to bone cell metabolism include lignans from flaxseed, and omega-3 fatty acids from flaxseed and fish oil. Flaxseed lignans can have biological activity similar to estrogen that our bodies naturally produce. Diets that contain higher amounts of omega-3 fatty acids have been shown to improve markers of bone status. The goal of the proposed research program is to determine if these food bioactives provide added benefits when provided with current pharmacological agents that help stabilize bone cell activity when it becomes unbalanced during aging. Pharmacological agents of interest include low dose estrogen (at a much lower dose than traditional estrogen therapy that is associated with elevated risk of developing breast cancer and heart disease), and selective estrogen or androgen receptor modulators that have positive effects on bone cell regulation without adverse effects in non-bone tissues. Studies will be conducted using well-established rat models that simulate the physiological changes in bone metabolism that occur in men and women during aging. Food bioactives in combination with pharmacological agents will be provided using these rat models. Findings from this research program may lead to the development of strategies that combine food bioactives and current pharmacological agents to more effectively normalize bone cell metabolism during aging. And specific mechanisms of action in bone cell metabolism will be determined.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
238916-2010
Name nom
Ward, Wendy
Department département
Physical Education & Kinesiology
Organization id
22
Institution établissement
Brock University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
21987
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6407
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Nutrition
Research subject fr
Nutrition
Partie
1
Nb partie
5
Application title
Food bioactives and bone metabolism
Keyword
NSERC
Application summary
Bone tissue begins to deteriorate as the body's ability to produce estrogen and testosterone is compromised with aging. Food bioactives, naturally present in foods such as flaxseed and fish oil, may help preserve normal bone cell function during aging. Food bioactives of particular interest to bone cell metabolism include lignans from flaxseed, and omega-3 fatty acids from flaxseed and fish oil. Flaxseed lignans can have biological activity similar to estrogen that our bodies naturally produce. Diets that contain higher amounts of omega-3 fatty acids have been shown to improve markers of bone status. The goal of the proposed research program is to determine if these food bioactives provide added benefits when provided with current pharmacological agents that help stabilize bone cell activity when it becomes unbalanced during aging. Pharmacological agents of interest include low dose estrogen (at a much lower dose than traditional estrogen therapy that is associated with elevated risk of developing breast cancer and heart disease), and selective estrogen or androgen receptor modulators that have positive effects on bone cell regulation without adverse effects in non-bone tissues. Studies will be conducted using well-established rat models that simulate the physiological changes in bone metabolism that occur in men and women during aging. Food bioactives in combination with pharmacological agents will be provided using these rat models. Findings from this research program may lead to the development of strategies that combine food bioactives and current pharmacological agents to more effectively normalize bone cell metabolism during aging. And specific mechanisms of action in bone cell metabolism will be determined.